Drugs / Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00450814 | Nov 2006 → Jul 2018 | plasma cell myeloma | Mayo Clinic | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00450814 ↗ |
| Route | Intravenous | “Given IV” NCT00450814 ↗ |